Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 6 consecutive quarters of double digit growth.
Click here to learn more ›

February 2022

Palatin Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update

Press Releases / By

– Initiated Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease with Topline Results Expected Second Half Calendar 2022 – Approximately $47.3 Million in Cash and Cash Equivalents at December 31, 2021 – Projected Cash Runway through March 31, 2023 – Phase 2 Clinical Study of PL8177 in Patients with Ulcerative Colitis …

Palatin Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update Read More »

Palatin to Report Second Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on February 15, 2022

Press Releases / By

Feb 10, 2022, 07:30 ET CRANBURY, N.J., Feb. 10, 2022 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter, fiscal year 2022 operating results on Tuesday, February 15, 2022, before the open of the U.S. financial markets. Palatin will also conduct a conference call and live audio webcast hosted by its executive …

Palatin to Report Second Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on February 15, 2022 Read More »

Scroll to Top